🔗 Share this article

A shadow economy for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Drug Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these accounts directly for source information, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on messaging services, where groups with thousands of participants share comparison photos, administration instructions and claims of next-day British shipping. Vendors market the substance there before redirecting customers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist individuals lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Experts Voice Worries

However, doctors and pharmacists have warned that the sale of what remains an unlicensed medication in the UK is worrisome and could lead to users injecting products of uncertain source.

Several experts stated the demand for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, risking fines, legal action or prison.

Platform Response and Material Elimination

According to the social media company, the platform has taken down problematic content and prohibited related keywords and search suggestions. The company said it was committed to maintaining the platform secure and allocating resources in enhancing compliance measures.

Digital Trading Operations

Research also discovered groups with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of members, populated with photos of slimming results, glowing reviews and detailed guides for preparing or administering at home.

After minutes of joining one community, a vendor shared contact information, where most purchases occur. The vendor provided an guidebook and promised shipping within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about weight, medical conditions or past usage.

Product Information and Pricing

Within these groups, posts display black plastic packages with Royal Mail labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled pens typically sold at £160 for 20 milligrams. When asked how long a pen should last, vendors give conflicting responses varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service said it actively moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering substances they can’t verify. Although the research behind this drug is sound, these digital versions may not include what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are using social media. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has previously encountered patients harmed by personal administration from unverified suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose users to potentially significant health risks”.